HepaPredict AB
Specialized CRO using 3D liver spheroids for drug toxicity prediction.
Overview
- 1–4
- Employees
- 1–2.5M SEK
- Revenue
- 2016
- Founded
Contacts
Volker Lauschke
Description
HepaPredict AB is a specialized Contract Research Organization (CRO) founded in 2016 as a spin-off from Karolinska Institutet. The company focuses intensely on drug metabolism, toxicity assessment, and drug development services specifically related to liver diseases. Their primary offering revolves...